Cargando…
Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243120/ https://www.ncbi.nlm.nih.gov/pubmed/35655097 http://dx.doi.org/10.1038/s41423-022-00865-2 |
| _version_ | 1784738233994706944 |
|---|---|
| author | Bullock, Timothy N. J. |
| author_facet | Bullock, Timothy N. J. |
| author_sort | Bullock, Timothy N. J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9243120 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92431202022-07-01 Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies Bullock, Timothy N. J. Cell Mol Immunol Correction Nature Publishing Group UK 2022-06-02 2022-07 /pmc/articles/PMC9243120/ /pubmed/35655097 http://dx.doi.org/10.1038/s41423-022-00865-2 Text en © The Author(s), under exclusive licence to CSI and USTC 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Bullock, Timothy N. J. Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies |
| title | Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies |
| title_full | Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies |
| title_fullStr | Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies |
| title_full_unstemmed | Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies |
| title_short | Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies |
| title_sort | correction: cd40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243120/ https://www.ncbi.nlm.nih.gov/pubmed/35655097 http://dx.doi.org/10.1038/s41423-022-00865-2 |
| work_keys_str_mv | AT bullocktimothynj correctioncd40stimulationasamolecularadjuvantforcancervaccinesandotherimmunotherapies |